/
Not financial advice. Analytical data for research only.
Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.
Company Overview Brainstorm Cell Therapeutics Inc. is a leading biotechnology company committed to the development and commercialization of best-in-class autologous cellular therapies for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis ( ALS , also known as Lou Gehrig s disease), progressive multiple sclerosis ( PMS ), Alzheimer s disease ( AD ), and other n…
$0.90
$0.08 (-8.16%)
EOD Sep 18, 2026
Negative free cash flow of -$7M. The business is consuming cash, not generating it.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue
N/A
Net Income (TTM)
-$11M
▲ +11.3% YoY
Op. Margin
—
ROIC
-704.35%
▲ +88.6pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$4M
▲ +23.4% YoY
Op. Cash Flow (TTM)
-$4M
▲ +23.3% YoY
Net Debt
$1M
Cash & Equiv.
$22K
Continue Research
SourceComputed from the 10-Q filed 14 Aug 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 15 Aug 2026. How this is calculated.
Price from market data, last close as of 18 Sept 2026. Fiscal year ends Dec. Sector medians are approximate S&P 500 benchmarks and update periodically.